Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CLBS stock: Caladrius Biosciences Inc

Current Rating
Sell

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$5.25
Market Cap
36.8M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.65
P/S
0.87
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-29K
FCF
-5.4
Op. Margin
-260.50%
Net Margin
-183.30%
ROE
-442.30%
ROI
-238.50%
ROA
-102.20%
EPS Growth
27.00%
Current Ratio
1.4
Debt/Equity
48.10%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Biostar Pharmaceuticals Inc (BSPM) $2.86 - - 7.7M Strong Buy
American Renal Associates Hold (ARA) $23.01 - - 591.7M Strong Buy
CYANOTECH CORP (CYAN) $4.15 - - 24.4M Strong Buy
Navidea Biopharmaceuticals Inc (NAVB) $0.49 - - 86.5M Strong Buy
Biomerica, Inc. (BMRA) $2.56 - - 23.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More